Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
71,316,848
-
Share change
-
-3,061,761
-
Total reported value
-
$706,106,704
-
Put/Call ratio
-
180%
-
Price per share
-
$9.90
-
Number of holders
-
122
-
Value change
-
-$54,676,467
-
Number of buys
-
70
-
Number of sells
-
54
Institutional Holders of ENDOLOGIX INC - COM (ELGX) as of Q4 2015
As of 31 Dec 2015,
ENDOLOGIX INC - COM (ELGX) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,316,848 shares.
The largest 10 holders included
JANUS CAPITAL MANAGEMENT LLC, CADIAN CAPITAL MANAGEMENT, LP, Tamarack Advisers, LP, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Arrowpoint Asset Management, LLC, TimesSquare Capital Management, LLC, Clearbridge Investments, LLC, and LORD, ABBETT & CO. LLC.
This page lists
122
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.